Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Equity Ratio: 2013-2024

Historic Equity Ratio for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Dec 2024 value amounting to 0.46.

  • Amphastar Pharmaceuticals' Equity Ratio fell 1.01% to 0.47 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.47, marking a year-over-year decrease of 1.01%. This contributed to the annual value of 0.46 for FY2024, which is 9.84% up from last year.
  • Amphastar Pharmaceuticals' Equity Ratio amounted to 0.46 in FY2024, which was up 9.84% from 0.42 recorded in FY2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Equity Ratio peaked at 0.71 during FY2022, and registered a low of 0.42 during FY2023.
  • Moreover, its 3-year median value for Equity Ratio was 0.46 (2024), whereas its average is 0.53.
  • In the last 5 years, Amphastar Pharmaceuticals' Equity Ratio slumped by 40.68% in 2023 and then climbed by 9.84% in 2024.
  • Amphastar Pharmaceuticals' Equity Ratio (Yearly) stood at 0.71 in 2020, then dropped by 6.67% to 0.66 in 2021, then climbed by 7.39% to 0.71 in 2022, then tumbled by 40.68% to 0.42 in 2023, then grew by 9.84% to 0.46 in 2024.